TY  - JOUR
AU  - Fernandez, Oscar
AU  - Izquierdo, Guillermo
AU  - Fernandez, Victoria
AU  - Leyva, Laura
AU  - Reyes, Virginia
AU  - Guerrero, Miguel
AU  - Leon, Antonio
AU  - Arnaiz, Carlos
AU  - Navarro, Guillermo
AU  - Paramo, Maria Dolores
AU  - De-la-Cuesta, Antonio 
AU  - Soria, Bernat
AU  - Hmadcha, Abdelkrim
AU  - Pozo, David
AU  - Fernandez-Montesinos, Rafael
AU  - Leal, Maria
AU  - Ochotorena, Itziar
AU  - Galvez, Patricia
AU  - Geniz, Maria Angeles
AU  - Baron, Francisco Javier
AU  - Mata, Rosario
AU  - Medina, Cristina
AU  - Caparros-Escudero, Carlos
AU  - Cardesa, Ana
AU  - Cuende, Natividad
PY  - 2018
DO  - 10.1371/journal.pone.0195891
UR  - http://hdl.handle.net/10668/12476
T2  - PloS one
AB  - Currently available treatments for secondary progressive multiple sclerosis(SPMS) have limited efficacy and/or safety concerns. Adipose-mesenchymal derived stem cells(AdMSCs) represent a promising option and can be readily obtained using minimally...
LA  - en
PB  - Public Library of Science
KW  - Adipose Tissue
KW  - Adult
KW  - Feasibility Studies
KW  - Female
KW  - Humans
KW  - Male
KW  - Mesenchymal Stem Cell Transplantation
KW  - Mesenchymal Stem Cells
KW  - Middle Aged
KW  - Multiple Sclerosis, Chronic Progressive
KW  - Treatment Outcome
TI  - Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study.
TY  - research article
VL  - 13
ER  -